Cargando…

Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma

The sympathoadrenal system has been shown to stimulate the secretory activity of enteroendocrine cells, although the response is transient. Our aim was to investigate the effects of long-term catecholamine excess on circulating glucagon-likepeptide-1 (GLP-1) levels in patients with pheochromocytoma/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Nan, Chen, Yan, Lai, Fenghua, Chen, Li, Zeng, Rui, Pei, Ling, Wu, Liting, Wang, Chenxue, Li, Yanbing, Xiao, Haipeng, Cao, Xiaopei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771646/ https://www.ncbi.nlm.nih.gov/pubmed/36569401 http://dx.doi.org/10.1155/2022/4203018

Ejemplares similares

Low Serum Creatinine Levels in Early Pregnancy Are Associated with a Higher Incidence of Postpartum Abnormal Glucose Metabolism among Women with Gestational Diabetes Mellitus: A Retrospective Cohort Study
por: Chen, Nan, et al.
Publicado: (2023)

Translation and validation of the Chinese version of medical maximizer-minimizer scale: a cross-sectional study
por: Lai, Fenghua, et al.
Publicado: (2021)

Pheochromocytomas and secreting paragangliomas
por: Plouin, Pierre-François, et al.
Publicado: (2006)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
por: Klímová, Judita, et al.
Publicado: (2019)

Elevated circulating level of a cytokine, pancreatic‐derived factor, is associated with metabolic syndrome components in a Chinese population
por: Cao, Xiaopei, et al.
Publicado: (2015)

Early postpartum abnormal glucose metabolism subtype differs according to mid-trimester lipid profile in women with gestational diabetes mellitus
por: Lai, Fenghua, et al.
Publicado: (2021)

Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Molecular markers of paragangliomas/pheochromocytomas
por: Zhikrivetskaya, Svetlana O, et al.
Publicado: (2017)

Characteristics of Pediatric Pheochromocytoma/paraganglioma
por: Sarathi, Vijaya
Publicado: (2017)

Review of Pediatric Pheochromocytoma and Paraganglioma
por: Bholah, Reshma, et al.
Publicado: (2017)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Metastatic Pheochromocytomas and Abdominal Paragangliomas
por: Granberg, Dan, et al.
Publicado: (2021)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

Impact of body composition and genotype on haemodynamics during surgery for pheochromocytoma and paraganglioma
por: Pang, Yingxian, et al.
Publicado: (2022)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
por: Ku, Eu Jeong, et al.
Publicado: (2021)

Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas
por: Meijs, Anouk C, et al.
Publicado: (2021)

Anesthetic management of pheochromocytoma and paraganglioma for patients with Fontan circulation: a case series
por: Tanaka, Yuto, et al.
Publicado: (2023)

Clinical differences between small and large pheochromocytomas and paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

A spontaneous paraganglioma–pheochromocytoma syndrome
por: Toutounchi, Sadegh, et al.
Publicado: (2013)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Paraganglioma or pheochromocytoma? A peculiar diagnosis
por: Marques, Ricardo Rodrigues, et al.
Publicado: (2018)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
por: Cascón, Alberto, et al.
Publicado: (2019)

Molecular Alterations in Dog Pheochromocytomas and Paragangliomas
por: Korpershoek, Esther, et al.
Publicado: (2019)

Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
por: Y-Hassan, Shams, et al.
Publicado: (2019)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

Update on Modern Management of Pheochromocytoma and Paraganglioma
por: Lenders, Jacques W. M., et al.
Publicado: (2017)

Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas
por: Y-Hassan, Shams, et al.
Publicado: (2020)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
por: Snezhkina, Anastasiya, et al.
Publicado: (2021)

Pheochromocytoma and Paraganglioma: Challenges and Opportunities in 2021
por: Takahashi, Katsutoshi
Publicado: (2021)

Perioperative Management of Pheochromocytomas and Sympathetic Paragangliomas
por: Fagundes, Gustavo F C, et al.
Publicado: (2022)

Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma
Publicado: (2021)

Erratum to: Personalized Management of Pheochromocytoma and Paraganglioma
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0e58l0tu1f8h7i3pc27ht6kqqi